APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tissue Heart Valves Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tissue Heart Valves Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17442936024 July 2026191 pages

Choose your research edition.

Industry ResearchTissue Heart Valves Device Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Tissue Heart Valves Device Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Tissue Heart Valves Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tissue Heart Valves Device Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tissue Heart Valves Device Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Tissue Heart Valves Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tissue Heart Valves Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tissue Heart Valves Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tissue Heart Valves Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tissue Heart Valves Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tissue Heart Valves Device include Boston Scientific Corporation, Comed BV, CryoLife, Edward Lifesciences Corporation, JenaValve Technology Inc, Meril Life Sciences, On-X Life Technologies, Inc, Sorin Group and TTK Healthcare Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tissue Heart Valves Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tissue Heart Valves Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tissue Heart Valves Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tissue Heart Valves Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Tissue Heart Valves Device Segment by Company

Boston Scientific Corporation

Comed BV

CryoLife

Edward Lifesciences Corporation

JenaValve Technology Inc

Meril Life Sciences

On-X Life Technologies, Inc

Sorin Group

TTK Healthcare Limited

Beijing Balance Medical Technology Co., Ltd

Medtronic

Abbott

Tissue Heart Valves Device Segment by Type

Aortic Valve

Tricuspid Valve

Pulmonary Valve

Mitral Valve

Tissue Heart Valves Device Segment by Application

Ambulatory Surgical Centers

Hospitals

Clinics

Tissue Heart Valves Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tissue Heart Valves Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tissue Heart Valves Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tissue Heart Valves Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tissue Heart Valves Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tissue Heart Valves Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tissue Heart Valves Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tissue Heart Valves Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tissue Heart Valves Device Industry Trends Table 2. Tissue Heart Valves Device Industry Drivers Table 3. Tissue Heart Valves Device Industry Opportunities and Challenges Table 4. Tissue Heart Valves Device Industry Restraints Table 5. Global Tissue Heart Valves Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tissue Heart Valves Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tissue Heart Valves Device Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Tissue Heart Valves Device Sales Market Share by Manufacturers Table 9. Global Tissue Heart Valves Device Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Tissue Heart Valves Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tissue Heart Valves Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tissue Heart Valves Device Manufacturers, Product Type & Application Table 13. Global Tissue Heart Valves Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tissue Heart Valves Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Aortic Valve Table 17. Major Manufacturers of Tricuspid Valve Table 18. Major Manufacturers of Pulmonary Valve Table 19. Major Manufacturers of Mitral Valve Table 20. Global Tissue Heart Valves Device Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Tissue Heart Valves Device Sales by Type (2021-2026) & (k units) Table 22. Global Tissue Heart Valves Device Sales by Type (2027-2032) & (k units) Table 23. Global Tissue Heart Valves Device Sales Market Share by Type (2021-2026) Table 24. Global Tissue Heart Valves Device Sales Market Share by Type (2027-2032) Table 25. Global Tissue Heart Valves Device Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Tissue Heart Valves Device Revenue by Type (2021-2026) & (k units) Table 27. Global Tissue Heart Valves Device Revenue by Type (2027-2032) & (k units) Table 28. Global Tissue Heart Valves Device Revenue Market Share by Type (2021-2026) Table 29. Global Tissue Heart Valves Device Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Ambulatory Surgical Centers Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Clinics Table 33. Global Tissue Heart Valves Device Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Tissue Heart Valves Device Sales by Application (2021-2026) & (k units) Table 35. Global Tissue Heart Valves Device Sales by Application (2027-2032) & (k units) Table 36. Global Tissue Heart Valves Device Sales Market Share by Application (2021-2026) Table 37. Global Tissue Heart Valves Device Sales Market Share by Application (2027-2032) Table 38. Global Tissue Heart Valves Device Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Tissue Heart Valves Device Revenue by Application (2021-2026) & (k units) Table 40. Global Tissue Heart Valves Device Revenue by Application (2027-2032) & (k units) Table 41. Global Tissue Heart Valves Device Revenue Market Share by Application (2021-2026) Table 42. Global Tissue Heart Valves Device Revenue Market Share by Application (2027-2032) Table 43. Global Tissue Heart Valves Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Tissue Heart Valves Device Sales by Region (2021-2026) & (k units) Table 45. Global Tissue Heart Valves Device Sales Market Share by Region (2021-2026) Table 46. Global Tissue Heart Valves Device Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Tissue Heart Valves Device Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Tissue Heart Valves Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Tissue Heart Valves Device Sales by Country (2021-2026) & (k units) Table 50. North America Tissue Heart Valves Device Sales by Country (2027-2032) & (k units) Table 51. Europe Tissue Heart Valves Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Tissue Heart Valves Device Sales by Country (2021-2026) & (k units) Table 53. Europe Tissue Heart Valves Device Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Tissue Heart Valves Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Tissue Heart Valves Device Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Tissue Heart Valves Device Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Tissue Heart Valves Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Tissue Heart Valves Device Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Tissue Heart Valves Device Sales by Country (2027-2032) & (k units) Table 60. Global Tissue Heart Valves Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Tissue Heart Valves Device Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Tissue Heart Valves Device Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Tissue Heart Valves Device Revenue Market Share by Region (2021-2026) Table 64. Global Tissue Heart Valves Device Revenue Market Share by Region (2027-2032) Table 65. Boston Scientific Corporation Company Information Table 66. Boston Scientific Corporation Business Overview Table 67. Boston Scientific Corporation Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Boston Scientific Corporation Tissue Heart Valves Device Product Portfolio Table 69. Boston Scientific Corporation Recent Development Table 70. Comed BV Company Information Table 71. Comed BV Business Overview Table 72. Comed BV Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Comed BV Tissue Heart Valves Device Product Portfolio Table 74. Comed BV Recent Development Table 75. CryoLife Company Information Table 76. CryoLife Business Overview Table 77. CryoLife Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. CryoLife Tissue Heart Valves Device Product Portfolio Table 79. CryoLife Recent Development Table 80. Edward Lifesciences Corporation Company Information Table 81. Edward Lifesciences Corporation Business Overview Table 82. Edward Lifesciences Corporation Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Edward Lifesciences Corporation Tissue Heart Valves Device Product Portfolio Table 84. Edward Lifesciences Corporation Recent Development Table 85. JenaValve Technology Inc Company Information Table 86. JenaValve Technology Inc Business Overview Table 87. JenaValve Technology Inc Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. JenaValve Technology Inc Tissue Heart Valves Device Product Portfolio Table 89. JenaValve Technology Inc Recent Development Table 90. Meril Life Sciences Company Information Table 91. Meril Life Sciences Business Overview Table 92. Meril Life Sciences Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Meril Life Sciences Tissue Heart Valves Device Product Portfolio Table 94. Meril Life Sciences Recent Development Table 95. On-X Life Technologies, Inc Company Information Table 96. On-X Life Technologies, Inc Business Overview Table 97. On-X Life Technologies, Inc Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. On-X Life Technologies, Inc Tissue Heart Valves Device Product Portfolio Table 99. On-X Life Technologies, Inc Recent Development Table 100. Sorin Group Company Information Table 101. Sorin Group Business Overview Table 102. Sorin Group Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Sorin Group Tissue Heart Valves Device Product Portfolio Table 104. Sorin Group Recent Development Table 105. TTK Healthcare Limited Company Information Table 106. TTK Healthcare Limited Business Overview Table 107. TTK Healthcare Limited Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. TTK Healthcare Limited Tissue Heart Valves Device Product Portfolio Table 109. TTK Healthcare Limited Recent Development Table 110. Beijing Balance Medical Technology Co., Ltd Company Information Table 111. Beijing Balance Medical Technology Co., Ltd Business Overview Table 112. Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Product Portfolio Table 114. Beijing Balance Medical Technology Co., Ltd Recent Development Table 115. Medtronic Company Information Table 116. Medtronic Business Overview Table 117. Medtronic Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Medtronic Tissue Heart Valves Device Product Portfolio Table 119. Medtronic Recent Development Table 120. Abbott Company Information Table 121. Abbott Business Overview Table 122. Abbott Tissue Heart Valves Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Abbott Tissue Heart Valves Device Product Portfolio Table 124. Abbott Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Tissue Heart Valves Device Distributors List Table 128. Tissue Heart Valves Device Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Tissue Heart Valves Device Product Image Figure 2. Global Tissue Heart Valves Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tissue Heart Valves Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Tissue Heart Valves Device Sales (2021-2032) & (k units) Figure 5. Global Tissue Heart Valves Device Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tissue Heart Valves Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Aortic Valve Image Figure 9. Tricuspid Valve Image Figure 10. Pulmonary Valve Image Figure 11. Mitral Valve Image Figure 12. Global Tissue Heart Valves Device Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Tissue Heart Valves Device Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Tissue Heart Valves Device Sales Market Share by Type (2021-2032) Figure 15. Global Tissue Heart Valves Device Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Tissue Heart Valves Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Tissue Heart Valves Device Revenue Market Share by Type (2021-2032) Figure 18. Ambulatory Surgical Centers Image Figure 19. Hospitals Image Figure 20. Clinics Image Figure 21. Global Tissue Heart Valves Device Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Tissue Heart Valves Device Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Tissue Heart Valves Device Sales Market Share by Application (2021-2032) Figure 24. Global Tissue Heart Valves Device Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Tissue Heart Valves Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Tissue Heart Valves Device Revenue Market Share by Application (2021-2032) Figure 27. North America Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Tissue Heart Valves Device Sales Market Share by Country (2021-2032) Figure 29. U.S. Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Tissue Heart Valves Device Sales Market Share by Country (2021-2032) Figure 34. Germany Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Tissue Heart Valves Device Sales Market Share by Country (2021-2032) Figure 41. China Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Tissue Heart Valves Device Sales Market Share by Country (2021-2032) Figure 49. Brazil Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Tissue Heart Valves Device Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Tissue Heart Valves Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Tissue Heart Valves Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Tissue Heart Valves Device Revenue (2021-2032) & (US$ Million) Figure 60. North America Tissue Heart Valves Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Tissue Heart Valves Device Revenue (2021-2032) & (US$ Million) Figure 62. Europe Tissue Heart Valves Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Tissue Heart Valves Device Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Tissue Heart Valves Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Tissue Heart Valves Device Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Tissue Heart Valves Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Tissue Heart Valves Device Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Tissue Heart Valves Device Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Aortic Valve
  • Tricuspid Valve
  • Pulmonary Valve
  • Mitral Valve
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Clinics
Companies covered
  • Boston Scientific Corporation
  • Comed BV
  • CryoLife
  • Edward Lifesciences Corporation
  • JenaValve Technology Inc
  • Meril Life Sciences
  • On-X Life Technologies, Inc
  • Sorin Group
  • TTK Healthcare Limited
  • Beijing Balance Medical Technology Co., Ltd
  • Medtronic
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tissue Heart Valves Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tissue Heart Valves Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tissue Heart Valves Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tissue Heart Valves Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tissue Heart Valves Device Market Dynamics
  1. 2.1 Tissue Heart Valves Device Industry Trends
  2. 2.2 Tissue Heart Valves Device Industry Drivers
  3. 2.3 Tissue Heart Valves Device Industry Opportunities and Challenges
  4. 2.4 Tissue Heart Valves Device Industry Restraints
3 Tissue Heart Valves Device Market by Manufacturers
  1. 3.1 Global Tissue Heart Valves Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tissue Heart Valves Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tissue Heart Valves Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tissue Heart Valves Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tissue Heart Valves Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tissue Heart Valves Device Manufacturers, Product Type & Application
  7. 3.7 Global Tissue Heart Valves Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tissue Heart Valves Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tissue Heart Valves Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tissue Heart Valves Device Tier 1, Tier 2, and Tier 3
4 Tissue Heart Valves Device Market by Type
  1. 4.1 Tissue Heart Valves Device Type Introduction
  2. 4.1.1 Aortic Valve
  3. 4.1.2 Tricuspid Valve
  4. 4.1.3 Pulmonary Valve
  5. 4.1.4 Mitral Valve
  6. 4.2 Global Tissue Heart Valves Device Sales by Type
  7. 4.2.1 Global Tissue Heart Valves Device Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Tissue Heart Valves Device Sales by Type (2021-2032)
  9. 4.2.3 Global Tissue Heart Valves Device Sales Market Share by Type (2021-2032)
  10. 4.3 Global Tissue Heart Valves Device Revenue by Type
  11. 4.3.1 Global Tissue Heart Valves Device Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Tissue Heart Valves Device Revenue by Type (2021-2032)
  13. 4.3.3 Global Tissue Heart Valves Device Revenue Market Share by Type (2021-2032)
5 Tissue Heart Valves Device Market by Application
  1. 5.1 Tissue Heart Valves Device Application Introduction
  2. 5.1.1 Ambulatory Surgical Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.2 Global Tissue Heart Valves Device Sales by Application
  6. 5.2.1 Global Tissue Heart Valves Device Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tissue Heart Valves Device Sales by Application (2021-2032)
  8. 5.2.3 Global Tissue Heart Valves Device Sales Market Share by Application (2021-2032)
  9. 5.3 Global Tissue Heart Valves Device Revenue by Application
  10. 5.3.1 Global Tissue Heart Valves Device Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tissue Heart Valves Device Revenue by Application (2021-2032)
  12. 5.3.3 Global Tissue Heart Valves Device Revenue Market Share by Application (2021-2032)
6 Global Tissue Heart Valves Device Sales by Region
  1. 6.1 Global Tissue Heart Valves Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tissue Heart Valves Device Sales by Region (2021-2032)
  3. 6.2.1 Global Tissue Heart Valves Device Sales by Region (2021-2026)
  4. 6.2.2 Global Tissue Heart Valves Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tissue Heart Valves Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tissue Heart Valves Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tissue Heart Valves Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tissue Heart Valves Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tissue Heart Valves Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tissue Heart Valves Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tissue Heart Valves Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tissue Heart Valves Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tissue Heart Valves Device Revenue by Region
  1. 7.1 Global Tissue Heart Valves Device Revenue by Region
  2. 7.1.1 Global Tissue Heart Valves Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tissue Heart Valves Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Tissue Heart Valves Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Tissue Heart Valves Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tissue Heart Valves Device Revenue (2021-2032)
  8. 7.2.2 North America Tissue Heart Valves Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tissue Heart Valves Device Revenue (2021-2032)
  11. 7.3.2 Europe Tissue Heart Valves Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tissue Heart Valves Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tissue Heart Valves Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tissue Heart Valves Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tissue Heart Valves Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Boston Scientific Corporation
  2. 8.1.1 Boston Scientific Corporation Company Information
  3. 8.1.2 Boston Scientific Corporation Business Overview
  4. 8.1.3 Boston Scientific Corporation Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Boston Scientific Corporation Tissue Heart Valves Device Product Portfolio
  6. 8.1.5 Boston Scientific Corporation Recent Developments
  7. 8.2 Comed BV
  8. 8.2.1 Comed BV Company Information
  9. 8.2.2 Comed BV Business Overview
  10. 8.2.3 Comed BV Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Comed BV Tissue Heart Valves Device Product Portfolio
  12. 8.2.5 Comed BV Recent Developments
  13. 8.3 CryoLife
  14. 8.3.1 CryoLife Company Information
  15. 8.3.2 CryoLife Business Overview
  16. 8.3.3 CryoLife Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CryoLife Tissue Heart Valves Device Product Portfolio
  18. 8.3.5 CryoLife Recent Developments
  19. 8.4 Edward Lifesciences Corporation
  20. 8.4.1 Edward Lifesciences Corporation Company Information
  21. 8.4.2 Edward Lifesciences Corporation Business Overview
  22. 8.4.3 Edward Lifesciences Corporation Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Edward Lifesciences Corporation Tissue Heart Valves Device Product Portfolio
  24. 8.4.5 Edward Lifesciences Corporation Recent Developments
  25. 8.5 JenaValve Technology Inc
  26. 8.5.1 JenaValve Technology Inc Company Information
  27. 8.5.2 JenaValve Technology Inc Business Overview
  28. 8.5.3 JenaValve Technology Inc Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 JenaValve Technology Inc Tissue Heart Valves Device Product Portfolio
  30. 8.5.5 JenaValve Technology Inc Recent Developments
  31. 8.6 Meril Life Sciences
  32. 8.6.1 Meril Life Sciences Company Information
  33. 8.6.2 Meril Life Sciences Business Overview
  34. 8.6.3 Meril Life Sciences Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Meril Life Sciences Tissue Heart Valves Device Product Portfolio
  36. 8.6.5 Meril Life Sciences Recent Developments
  37. 8.7 On-X Life Technologies, Inc
  38. 8.7.1 On-X Life Technologies, Inc Company Information
  39. 8.7.2 On-X Life Technologies, Inc Business Overview
  40. 8.7.3 On-X Life Technologies, Inc Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 On-X Life Technologies, Inc Tissue Heart Valves Device Product Portfolio
  42. 8.7.5 On-X Life Technologies, Inc Recent Developments
  43. 8.8 Sorin Group
  44. 8.8.1 Sorin Group Company Information
  45. 8.8.2 Sorin Group Business Overview
  46. 8.8.3 Sorin Group Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sorin Group Tissue Heart Valves Device Product Portfolio
  48. 8.8.5 Sorin Group Recent Developments
  49. 8.9 TTK Healthcare Limited
  50. 8.9.1 TTK Healthcare Limited Company Information
  51. 8.9.2 TTK Healthcare Limited Business Overview
  52. 8.9.3 TTK Healthcare Limited Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 TTK Healthcare Limited Tissue Heart Valves Device Product Portfolio
  54. 8.9.5 TTK Healthcare Limited Recent Developments
  55. 8.10 Beijing Balance Medical Technology Co., Ltd
  56. 8.10.1 Beijing Balance Medical Technology Co., Ltd Company Information
  57. 8.10.2 Beijing Balance Medical Technology Co., Ltd Business Overview
  58. 8.10.3 Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Balance Medical Technology Co., Ltd Tissue Heart Valves Device Product Portfolio
  60. 8.10.5 Beijing Balance Medical Technology Co., Ltd Recent Developments
  61. 8.11 Medtronic
  62. 8.11.1 Medtronic Company Information
  63. 8.11.2 Medtronic Business Overview
  64. 8.11.3 Medtronic Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Medtronic Tissue Heart Valves Device Product Portfolio
  66. 8.11.5 Medtronic Recent Developments
  67. 8.12 Abbott
  68. 8.12.1 Abbott Company Information
  69. 8.12.2 Abbott Business Overview
  70. 8.12.3 Abbott Tissue Heart Valves Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Abbott Tissue Heart Valves Device Product Portfolio
  72. 8.12.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tissue Heart Valves Device Value Chain Analysis
  2. 9.1.1 Tissue Heart Valves Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tissue Heart Valves Device Production Mode & Process
  6. 9.2 Tissue Heart Valves Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tissue Heart Valves Device Distributors
  9. 9.2.3 Tissue Heart Valves Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst